ID

20420

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Stichworte

Versionen (1)
  1. 22.02.17 22.02.17 -
Hochgeladen am

22. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Englisch

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare  
Permanent Trial Medication
Beschreibung

Permanent Trial Medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0205355
1. Last intake of trial drug A, B and C (dd mon yy)
Beschreibung

Last Intake of Drug A, B and C

Datentyp

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
2. Last intake of trial drug D (dd mon yy)
Beschreibung

Last Intake of Drug D

Datentyp

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
3. Did the patient permanently stopped taking any of the trial medication prematurely
Beschreibung

Permanently stopped taking medication

Datentyp

boolean

Alias
UMLS CUI [1]
C0850893
arm of the trial medication
Beschreibung

arm of the trial medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0332307
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
Beschreibung

If Yes

Datentyp

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0457454
A. Outcome Event (must be recorded on outcome event page)
Beschreibung

Outcome events

Datentyp

integer

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C1547647
UMLS CUI [1,3]
C0441471
B. Adverse Event (Specify Adverse Event below)
Beschreibung

Adverse Event

Datentyp

integer

Alias
UMLS CUI [1]
C0877248
Specify Adverse Event
Beschreibung

Adverse Event

Datentyp

text

Alias
UMLS CUI [1,1]
C2348235
UMLS CUI [1,2]
C0877248
C. Non compliant with protocol (explain below)
Beschreibung

Non Compliant With Protocol

Datentyp

integer

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
D. Lost to follow-up (explain below)
Beschreibung

Lost to follow-up

Datentyp

integer

Alias
UMLS CUI [1]
C1522577
E. Consent withdrawn (not due to adverse event, explain below)
Beschreibung

Consent withdrawn

Datentyp

integer

Alias
UMLS CUI [1]
C1707492
F. Other (explain below)
Beschreibung

Other

Datentyp

integer

Alias
UMLS CUI [1]
C0205394
Explain
Beschreibung

Explain

Datentyp

text

Alias
UMLS CUI [1]
C1521902
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Permanent Trial Medication
C0013227 (UMLS CUI-1)
C0205355 (UMLS CUI-2)
Last Intake of Drug A, B and C
Item
1. Last intake of trial drug A, B and C (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Last Intake of Drug D
Item
2. Last intake of trial drug D (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Permanently stopped taking medication
Item
3. Did the patient permanently stopped taking any of the trial medication prematurely
boolean
C0850893 (UMLS CUI [1])
Item Group
arm of the trial medication
C0013227 (UMLS CUI-1)
C0332307 (UMLS CUI-2)
If Yes
Item
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Item
A. Outcome Event (must be recorded on outcome event page)
integer
C0441471 (UMLS CUI [1,1])
C1547647 (UMLS CUI [1,2])
C0441471 (UMLS CUI [1,3])
Outcome events
Code List
A. Outcome Event (must be recorded on outcome event page)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
B. Adverse Event (Specify Adverse Event below)
integer
C0877248 (UMLS CUI [1])
Outcome events
Code List
B. Adverse Event (Specify Adverse Event below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Adverse Event
Item
Specify Adverse Event
text
C2348235 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item
C. Non compliant with protocol (explain below)
integer
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Outcome events
Code List
C. Non compliant with protocol (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
D. Lost to follow-up (explain below)
integer
C1522577 (UMLS CUI [1])
Outcome events
Code List
D. Lost to follow-up (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
E. Consent withdrawn (not due to adverse event, explain below)
integer
C1707492 (UMLS CUI [1])
Outcome events
Code List
E. Consent withdrawn (not due to adverse event, explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
F. Other (explain below)
integer
C0205394 (UMLS CUI [1])
Outcome events
Code List
F. Other (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Explain
Item
Explain
text
C1521902 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video